Given its putative mitochondrial association and sequence homology, CHCHD2P9 warrants further investigation as a potentially novel regulatory molecule in glioma biology, although current evidence does not yet support its classification as a bona fide mitochondrial protein (14). The gene discussed is CHCHD2P9; the disease is central nervous system cancer.